Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/09/23
End: 03/28/25
Due: 03/28/26
Phase: N/A
Priority: Normal
Start: 03/17/25
End: 04/21/25
Due: 04/21/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects | NCT05735249 | Arisan Therapeutics, Inc. | user2@example.com | None | 2023-01-09 | 2025-03-28 | 2026-03-28 | - | - | 2025-07-14 |
| A Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions | NCT06911242 | Arisan Therapeutics, Inc. | user2@example.com | None | 2025-03-17 | 2025-04-21 | 2026-04-21 | - | - | 2025-07-14 |